Is intravesical BCG treatment necessary and/or sufficient?

dc.contributor.authorEkici, S.
dc.contributor.authorTurker, Polat
dc.date.accessioned2024-07-12T21:40:54Z
dc.date.available2024-07-12T21:40:54Z
dc.date.issued2013en_US
dc.department[Belirlenecek]en_US
dc.description.abstractIntravesical BCG treatment has been used over 3 decades in the treatment of non-muscle invasive bladder cancer. Although the exact mechanism of its action is not clear, its clinical efficiency has been proven. Numerous clinical trials are still trying to answer; which tumoral lesions this drug should be used for, which dosage is enough, which maintanence should be chosen and how long it should be continued. In this article the answers of these questions, with the current evidence, are summarised.en_US
dc.identifier.endpage25en_US
dc.identifier.issn2147-2270
dc.identifier.issue1en_US
dc.identifier.startpage22en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/7545
dc.identifier.volume12en_US
dc.identifier.wosWOS:000219391600006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Science
dc.language.isotren_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofUroonkoloji Bulteni-Bulletin of Urooncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY09393
dc.subjectNon-Muscle Invasive Bladder Canceren_US
dc.subjectIntravesical Therapyen_US
dc.subjectBcgen_US
dc.titleIs intravesical BCG treatment necessary and/or sufficient?en_US
dc.typeReview Article
dspace.entity.typePublication

Dosyalar